We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Cardiology

Journal Scan / Research · December 07, 2020

Spironolactone Use and Improved Outcomes in Patients With HFpEF With Resistant Hypertension

Journal of the American Heart Association

 

Additional Info

Journal of the American Heart Association
Spironolactone Use and Improved Outcomes in Patients With Heart Failure With Preserved Ejection Fraction With Resistant Hypertension
J Am Heart Assoc 2020 Nov 23;[EPub Ahead of Print], T Tsujimoto, H Kajio

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading